11-74493434-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001144869.3(LIPT2):c.270C>A(p.Thr90=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000653 in 1,505,074 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0035 ( 3 hom., cov: 34)
Exomes 𝑓: 0.00033 ( 1 hom. )
Consequence
LIPT2
NM_001144869.3 synonymous
NM_001144869.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.513
Genes affected
LIPT2 (HGNC:37216): (lipoyl(octanoyl) transferase 2) This gene encodes a mitochondrial protein that catalyzes the transfer of octanoic acid to lipoate-dependent enzymes such as octanoyl-ACP. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 11-74493434-G-T is Benign according to our data. Variant chr11-74493434-G-T is described in ClinVar as [Benign]. Clinvar id is 716319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.513 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LIPT2 | NM_001144869.3 | c.270C>A | p.Thr90= | synonymous_variant | 1/2 | ENST00000310109.5 | |
LIPT2-AS1 | NR_171028.1 | n.55G>T | non_coding_transcript_exon_variant | 1/2 | |||
LIPT2 | NM_001329941.2 | c.270C>A | p.Thr90= | synonymous_variant | 1/2 | ||
LIPT2 | NM_001329942.2 | c.237+33C>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LIPT2 | ENST00000310109.5 | c.270C>A | p.Thr90= | synonymous_variant | 1/2 | 2 | NM_001144869.3 | P1 | |
LIPT2-AS1 | ENST00000526036.1 | n.69G>T | non_coding_transcript_exon_variant | 1/2 | 1 | ||||
LIPT2 | ENST00000528085.1 | c.181+33C>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00348 AC: 530AN: 152204Hom.: 3 Cov.: 34
GnomAD3 genomes
AF:
AC:
530
AN:
152204
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000229 AC: 23AN: 100328Hom.: 0 AF XY: 0.000196 AC XY: 11AN XY: 56028
GnomAD3 exomes
AF:
AC:
23
AN:
100328
Hom.:
AF XY:
AC XY:
11
AN XY:
56028
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000335 AC: 453AN: 1352758Hom.: 1 Cov.: 43 AF XY: 0.000253 AC XY: 169AN XY: 666948
GnomAD4 exome
AF:
AC:
453
AN:
1352758
Hom.:
Cov.:
43
AF XY:
AC XY:
169
AN XY:
666948
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00348 AC: 530AN: 152316Hom.: 3 Cov.: 34 AF XY: 0.00330 AC XY: 246AN XY: 74490
GnomAD4 genome
AF:
AC:
530
AN:
152316
Hom.:
Cov.:
34
AF XY:
AC XY:
246
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3464
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | ENSG00000254837: BS1, BS2; LIPT2: BP4, BP7, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | - - |
LIPT2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 10, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at